Sunday, February 5, 2023

Ozempic, the fashionable antidiabetic that is missing in pharmacies

Ozempic, a drug indicated for people with type 2 diabetes, has been in short supply for months in pharmacies around the world, including Spain. The reason, an exponential increase in demand, sponsored by influencers, who have caused an alarming buzz on social networks because of their slimming effect.

Experts send a message of reassurance to diabetics as they have options for this drug, but it is important that they reach out to their doctor to make treatment changes while supplies of Ozempic, which began causing problems in October, Has recovered, points Ana de Hollanda, an endocrinologist at the Hospital Clínic de Barcelona.

But they stress that it is a prescription drug and taking it without medical supervision can have consequences. “If you use it without control, you will feel a loss of appetite and quickly lose fat and even muscle, but when you stop, you will have the opposite effect ,” say his colleagues at the Virgen Macarena University Hospital in Seville. , Cristóbal Morales.

It is not a magic wand. Patients who are funded for Ozempic pay a little over four euros, compared to the 130 euros that each pen costs outside the national health system.

These drugs, in addition to controlling glucose levels, suppress appetite, which favors weight loss, although always in combination with proper diet and exercise. Clinical trials have also shown very positive results for reducing the risk of heart diseases associated with diabetes.

All of this has fueled demand: In the US, one of the countries with the highest obesity rates in the world, supply problems for Vegovy (which has not yet reached Europe) have led to over-use Ozempic as an alternative…

Nation World News Desk
Nation World News Deskhttps://nationworldnews.com
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news